KurCoSmart Effects on People With Type 2 DM

Universitas Sebelas Maret

Status and phase: Not yet enrolling; Phase 2; Phase 1

Conditions: Inflammation; Insulin Resistance; Body Weight; Diabetes Mellitus, Type 2

Treatments: Dietary Supplement: Curcumin and virgin coconut oil extract (KurCo Smart)

Study type: Interventional

Funder types: Other

Identifiers

NCT05407467

KurCoSmart

Details and patient eligibility

About

The investigators aim to evaluate the effect of curcumin and virgin coconut oil extract supplementation on people with type 2 DM, including blood glucose, HbA1c levels, inflammation, body weight and insulin resistance evaluation

Full description

The investigators give Kurcosmart supplementation aside from diabetes standard treatment to evaluate its benefits on people with type 2 DM, considering its effect on controlling fasting and prandial blood glucose, reducing HbA1c level, controlling inflammation degree; and repairing insulin resistance

Enrollment: 40 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Confirmed Type 2 DM
• Signing consent form

Exclusion criteria

• Pregnant or breastfeeding
• Multiple organ failure
• History of hypersensitivity reaction to curcumin and virgin coconut oil
• Cancer, renal insufficiency, hematological disease, acute heart failure, chronic liver disease

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Double Blind

---

40 participants in 2 patient groups

Control Group

No Intervention group

Description:

There is no additional intervention other than subject's standard diabetes treatment

Interventional Group

Experimental group

Description:

This group will received additional supplementation of curcumin and virgin coconut oil aside from their standard treatment

Treatment:

Dietary Supplement: Curcumin and virgin coconut oil extract (KurCo Smart)